By Tony Fong

NEW YORK (GenomeWeb News) – Synpromics, which is developing synthetic promoters for applications in diagnostics development, gene therapeutics, and research use, has launched.

The company is currently in discussions with several life science vendors and gene therapeutics firms to codevelop and comarket the promoters, Michael Roberts, its founder and managing director, told GenomeWeb Daily News.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.